Embla Medical hf: Conference call details for Q3 2024
Embla Medical (Nasdaq Copenhagen: EMBLA) will publish its Q3 2024 Interim Report on October 22, 2024, at 7:00 CET. A conference call will be hosted on the same date at 9:00 CET / 7:00 GMT / 3:00am EST. The event will be hosted by Sveinn Solvason, President and CEO, and G. Arna Sveinsdottir, CFO. The call will include a review of the quarterly results and will be held in English. Slides used in the presentation will be made available on the company website at the following link: http://www.emblamedical.com/investors The conference call webcast can be accessed through following link: